Solifenacin Succinate

Product description

Solifenacin is an active substance for the treatment of overactive bladder. It is administered in the form of film-coated tablets.

Comprehensive documentation for drug registration of Solifenacin can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
242478-38-2 ASMF EP, USP

Tradename(s)

Solifenacin Succinate (Antimuscarinic)

Country availability

Available worldwide

Georges Bertagne

Contact person

Georges Bertagne

General Manager


email   phone

Contact person

Brigitte Favre Bonnefoy

Head of Sales


email   phone